ADELAIDE, Australia – TGR BioSciences, a leading global provider of advanced cell based assay technologies in the fields of cancer, kinase and GPCR research, is extremely pleased to announce a distribution partnership with Cedarlane Laboratories of Burlington, ON, Canada, a leading supplier of Life Science research reagents in North America. Cedarlane will become a distributor […]
Burlingame, CA – Epitomics and NCI to Develop Novel Antibodies Using Epitomics Technology Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) […]
Genovis, a producer of new technologies used for Imaging and Antibody Engineering, today announced that it has entered into an agreement with ADVANSYS Technologies for Life Ltd. to exclusive distribute its products on the Israeli market. Genovis provides novel technical solutions for Imaging and Antibody Engineering. The objectives are to maintain a strong, collaborative and […]
MADISON, WISCONSIN – Promega Corporation reinforces its commitment to socially responsible business practices on a worldwide basis by signing the United Nations Global Compact. The UN Global Compact is a policy initiative for businesses that are committed to supporting the Compact’s ten universally accepted principles in the areas of human rights, labour, environment and anti-corruption. […]
Biodegradable transfection reagents now available through e-commerce site PHILADELPHIA – Techulon Inc., an early stage life sciences company has joined KFP—the KeraFAST Partner Program, adding its innovative new transfection reagent, Glycofect™, to KeraFAST’s portfolio of research products for the cell biologist. The agreement was announced during the 50th Annual Meeting of the American Society for […]
Horizon Discovery (Horizon), a leading provider of research tools to support the development of personalized medicines,has announced that it will commit resources to provide training and open access to its rAAV GENESIS human gene-editing platform for another 50 academic and not-for-profit research groups over the next five years, extending the GENESIS Gene Editing Consortium. This […]
International Stem Cell Corporation (OTCBB:ISCO), www.internationalstemcell.com, announced today that it had entered into an agreement with Aspire Capital Fund, LLC, to provide, at the Company’s sole option, up to $25 million of equity capital over the next three years. As part of this transaction, Aspire purchased, upon execution of the agreement, 333,333 shares of ISCO […]
Scientific breakthrough by Sigma Advanced Genetic Engineering (SAGE™) Labs enables creation of more sophisticated models of human disease ST. LOUIS – Sigma Life Science, the innovative biological products and services business of Sigma-Aldrich® (Nasdaq: SIAL), today announced that its SAGE Labs initiative has successfully used its proprietary CompoZr® Zinc Finger Nuclease (ZFN) technology to generate […]
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today the signing of a non-exclusive license and technology transfer agreement between its subsidiary Sloning BioTechnology GmbH and Pfizer. The agreement covers the installation, training and use of Sloning’s technology platform Slonomics® for fabrication of highly-diverse gene and protein libraries at Pfizer’s subsidiary Rinat Neuroscience Corp. […]
World’s only Mc4r Knockout Rat Model to be available through Taconic Hudson, New York – Taconic, a leading global provider of research models and services, and Transposagen Biopharmaceuticals, Inc. (Transposagen), the worldwide leader in genetically modified rats, announced today that they have entered into a non-exclusive marketing and distribution agreement. Under the agreement, Taconic will […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
